​

Cingulate (CING) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

CING Stock Forecast

Cingulate (CING) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $11.00 and a low of $11.00. This represents a 150.00% increase from the last price of $4.40.

- $3 $6 $9 $12 $15 High: $11 Avg: $11 Low: $11 Last Closed Price: $4.4

CING Stock Rating

Cingulate stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

CING Price Target Upside V Benchmarks

TypeNameUpside
StockCingulate150.00%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$11.00$11.00$11.00
Last Closing Price$4.40$4.40$4.40
Upside/Downside150.00%150.00%150.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2531---4
May, 2531---4
Apr, 253----3
Mar, 2531---4
Feb, 2531---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 19, 2025Boobalan PachaiyappanRoth Capital$11.00$3.82187.96%150.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 19, 2025Roth CapitalBuyBuyhold
Jan 30, 2025H.C. WainwrightBuyBuyhold
Nov 20, 2024Maxim GroupBuyupgrade

Financial Forecast

EPS Forecast

$-350 $-270 $-190 $-110 $-30 $50 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-311.99-----
Avg Forecast$-333.21$-10.96$-4.53$-1.39$-0.48$1.31
High Forecast$-333.21$-8.44$-1.88$-0.27$-0.48$1.31
Low Forecast$-333.21$-15.52$-6.64$-2.50$-0.48$1.31
Surprise %-6.37%-----

Revenue Forecast

$5M $9M $13M $17M $21M $25M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$18.65M$7.77M$9.51M$21.01M
High Forecast--$18.65M$7.77M$9.51M$21.01M
Low Forecast--$18.65M$7.77M$9.51M$21.01M
Surprise %------

Net Income Forecast

$-30M $-23M $-16M $-9M $-2M $5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.53M$-15.55M----
Avg Forecast$-25.14M$-903.95K$-321.32K$-104.48K$-36.21K$98.82K
High Forecast$-25.14M$-637.04K$-141.93K$-20.37K$-36.21K$98.82K
Low Forecast$-25.14M$-1.17M$-500.71K$-188.59K$-36.21K$98.82K
Surprise %-6.37%1619.79%----

CING Forecast FAQ

Is Cingulate stock a buy?

Cingulate stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cingulate is a favorable investment for most analysts.

What is Cingulate's price target?

Cingulate's price target, set by 6 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $11 at the low end to $11 at the high end, suggesting a potential 150.00% change from the previous closing price of $4.4.

How does Cingulate stock forecast compare to its benchmarks?

Cingulate's stock forecast shows a 150.00% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Cingulate over the past three months?

  • June 2025: 75.00% Strong Buy, 25.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 75.00% Strong Buy, 25.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Cingulate’s EPS forecast?

Cingulate's average annual EPS forecast for its fiscal year ending in December 2025 is $-4.53, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-1.39 in 2026, $-0.48 in 2027, and $1.31 in 2028.

What is Cingulate’s revenue forecast?

Cingulate's average annual revenue forecast for its fiscal year ending in December 2025 is $18.65M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $7.77M, followed by $9.51M for 2027, and $21.01M for 2028.

What is Cingulate’s net income forecast?

Cingulate's net income forecast for the fiscal year ending in December 2025 stands at $-321K, representing a -97.93% decrease from the reported $-15.546M in 2024. Projections indicate $-104K in 2026, $-36.209K in 2027, and $98.82K in 2028.